Intellectual Property India Publishes Patent Application for 'Derivatives Of Substituted Morpholines And Uses Thereof' Filed by Supernus Pharmaceuticals, Inc.

MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202527082821 A) filed by Supernus Pharmaceuticals, Inc., Rockville, U.S.A., on Sept. 1, for 'derivatives of substituted morpholines and uses thereof.'

Inventor(s) include Padia, Janak Khimchand; and Yu, Chungping.

The application for the patent was published on Sept. 26, under issue no. 39/2025.

According to the abstract released by the Intellectual Property India: "A compound of Formula I includes a stereoisomer thereof and/or a salt thereof; wherein R1 is a substituted alkane group, a heterocylic group, or a pyridine group; X is hydrogen, a halogen, an amino acid residue, a substituted amino acid residue, an alkyl group, or an ester. Such compounds may be used in pharmaceutical compositions and for the treatment of central nervous system (CNS) disorders: (I)."

The patent application was internationally filed on Mar. 26, 2024, under International application No.PCT/US2024/021473.

Disclaimer: Curated by HT Syndication.